Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

67 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Diabetes mellitus following cisplatin treatment.
Nan DN, Fernández-Ayala M, Vega Villegas ME, Garcia-Castaño A, Rivera F, Lopez-Brea M, González-Macías J. Nan DN, et al. Acta Oncol. 2003;42(1):75-8. doi: 10.1080/0891060310002276. Acta Oncol. 2003. PMID: 12665335
Long-term results of a phase II trial of induction chemotherapy with uracil-ftegafur (UFT), vinorelbine, and cisplatin (UFTVP) followed by radiotherapy concomitant with UFT and carboplatin (RT/UFTJ) in a primary site preservation setting for resectable locally advanced squamous cell carcinoma of larynx and hypopharynx.
Rivera F, Vega-Villegas ME, López-Brea MF, García-Castaño A, de Juan A, Collado A, Galdós P, Rubio A, del Valle A, Rama J, Sanz-Ortiz J. Rivera F, et al. Laryngoscope. 2004 Jul;114(7):1163-9. doi: 10.1097/00005537-200407000-00006. Laryngoscope. 2004. PMID: 15235341 Clinical Trial.
Long term results of a phase II trial of induction chemotherapy with uracil-ftegafur (UFT), vinorelbine and cisplatin (UFTVP) followed by radiotherapy concomitant with UFT and carboplatin (RT/UFTJ) in non-resectable locally advanced (stage IV-B) squamous cell head and neck carcinoma and peripheral blood stem cell support (PBSCS) with febrile neutropenia.
Rivera F, Vega-Villegas ME, López-Brea MF, García-Castaño A, de Juan A, Ramos FJ, Collado A, Galdós P, Rubio A, del Valle A, Rama J, Mayorga M, Sanz-Ortiz J. Rivera F, et al. Clin Transl Oncol. 2007 Jan;9(1):40-7. doi: 10.1007/s12094-007-0008-5. Clin Transl Oncol. 2007. PMID: 17272229 Clinical Trial.
A genome-wide association study yields five novel thyroid cancer risk loci.
Gudmundsson J, Thorleifsson G, Sigurdsson JK, Stefansdottir L, Jonasson JG, Gudjonsson SA, Gudbjartsson DF, Masson G, Johannsdottir H, Halldorsson GH, Stacey SN, Helgason H, Sulem P, Senter L, He H, Liyanarachchi S, Ringel MD, Aguillo E, Panadero A, Prats E, Garcia-Castaño A, De Juan A, Rivera F, Xu L, Kiemeney LA, Eyjolfsson GI, Sigurdardottir O, Olafsson I, Kristvinsson H, Netea-Maier RT, Jonsson T, Mayordomo JI, Plantinga TS, Hjartarson H, Hrafnkelsson J, Sturgis EM, Thorsteinsdottir U, Rafnar T, de la Chapelle A, Stefansson K. Gudmundsson J, et al. Nat Commun. 2017 Feb 14;8:14517. doi: 10.1038/ncomms14517. Nat Commun. 2017. PMID: 28195142 Free PMC article.
Gold glyconanoparticles coupled to listeriolysin O 91-99 peptide serve as adjuvant therapy against melanoma.
Calderon-Gonzalez R, Terán-Navarro H, García I, Marradi M, Salcines-Cuevas D, Yañez-Diaz S, Solis-Angulo A, Frande-Cabanes E, Fariñas MC, Garcia-Castaño A, Gomez-Roman J, Penades S, Rivera F, Freire J, Álvarez-Domínguez C. Calderon-Gonzalez R, et al. Nanoscale. 2017 Aug 3;9(30):10721-10732. doi: 10.1039/c7nr02494k. Nanoscale. 2017. PMID: 28714508
Dendritic cell therapy in melanoma.
Alvarez-Dominguez C, Calderón-Gonzalez R, Terán-Navarro H, Salcines-Cuevas D, Garcia-Castaño A, Freire J, Gomez-Roman J, Rivera F. Alvarez-Dominguez C, et al. Ann Transl Med. 2017 Oct;5(19):386. doi: 10.21037/atm.2017.06.13. Ann Transl Med. 2017. PMID: 29114544 Free PMC article. Review.
Pre-clinical development of Listeria-based nanovaccines as immunotherapies for solid tumours: insights from melanoma.
Terán-Navarro H, Calderon-Gonzalez R, Salcines-Cuevas D, García I, Marradi M, Freire J, Salmon E, Portillo-Gonzalez M, Frande-Cabanes E, García-Castaño A, Martinez-Callejo V, Gomez-Roman J, Tobes R, Rivera F, Yañez-Diaz S, Álvarez-Domínguez C. Terán-Navarro H, et al. Oncoimmunology. 2018 Nov 10;8(2):e1541534. doi: 10.1080/2162402X.2018.1541534. eCollection 2019. Oncoimmunology. 2018. PMID: 30713801 Free PMC article.
SEOM clinical guidelines for the treatment of head and neck cancer (2020).
Mesia R, Iglesias L, Lambea J, Martínez-Trufero J, Soria A, Taberna M, Trigo J, Chaves M, García-Castaño A, Cruz J. Mesia R, et al. Clin Transl Oncol. 2021 May;23(5):913-921. doi: 10.1007/s12094-020-02533-1. Epub 2021 Feb 26. Clin Transl Oncol. 2021. PMID: 33635468 Free PMC article.
Gold Glyconanoparticles Combined with 91-99 Peptide of the Bacterial Toxin, Listeriolysin O, Are Efficient Immunotherapies in Experimental Bladder Tumors.
Terán-Navarro H, Zeoli A, Salines-Cuevas D, Marradi M, Montoya N, Gonzalez-Lopez E, Ocejo-Vinyals JG, Dominguez-Esteban M, Gutierrez-Baños JL, Campos-Juanatey F, Yañez-Diaz S, Garcia-Castaño A, Rivera F, Duran I, Alvarez-Dominguez C. Terán-Navarro H, et al. Cancers (Basel). 2022 May 13;14(10):2413. doi: 10.3390/cancers14102413. Cancers (Basel). 2022. PMID: 35626016 Free PMC article.
67 results